Rankings
▼
Calendar
TBPH Q1 2019 Earnings — Theravance Biopharma, Inc. Revenue & Financial Results | Market Cap Arena
TBPH
Theravance Biopharma, Inc.
$697M
Q1 2019 Earnings
Healthcare
Biotechnology
Income Statement
Revenue
$5M
-35.8% YoY
Gross Profit
-$48M
-908.2% margin
Operating Income
-$74M
-1380.0% margin
Net Income
-$73M
-1359.7% margin
EPS (Diluted)
$-1.32
QoQ Revenue Growth
-66.1%
Cash Flow
Operating Cash Flow
-$81M
Free Cash Flow
-$82M
Stock-Based Comp.
$12M
Balance Sheet
Total Assets
$531M
Total Liabilities
$645M
Stockholders' Equity
-$113M
Cash & Equivalents
$223M
Year-over-Year Comparison
Metric
Current
Year Ago
Change
Revenue
$5M
$8M
-35.8%
Gross Profit
-$48M
$7M
-747.0%
Operating Income
-$74M
-$65M
-13.4%
Net Income
-$73M
-$65M
-11.5%
Revenue Segments
Collaborative Arrangement Revenue
$5M
100%
← FY 2019
All Quarters
Q2 2019 →